IQV - IQVIA Holdings Inc. Pick

Research brief

Oct 27, 2026 Morning

01:00 PM UTC

IQVIA Holdings Inc. IQV low

IQV

Conf. Low

Pick Pr. $275.50

Stop Pr. $266.00

Curr. Pr. $272.96

Change -0.92%

Rem. Days 7

Summary

BUY IQVIA (IQV), Momentum; Low confidence. The decider's research entry is $274.45001220703125 at October 27, 2026, 10:43 EDT. The latest publication observation is $274.2099914550781 at 10:56 EDT, retrieved at 10:57:33 EDT. These are market-data indications, not executed fills. finance.yahoo
The catalyst is released, not pending: IQVIA's October 27, 07:00 EDT results reported revenue growth of 8%, adjusted EPS growth of 11.3% and R&D bookings growth of 15%. The guidance increase is small and acquisition-qualified, not a verified organic outlook upgrade. businesswire
Decider estimates: the original seven-day policy forecast is +0.1890% net, versus +0.1157% for matched-horizon SPY. Its +0.0733 percentage-point excess becomes −1.3867 points after 1.46 points of model uncertainty. This is a fragile positive absolute-return forecast, not statistically demonstrated alpha.
Risk plan: retain the authored $266 stop threshold, $263.50 conditional actual stop-exit estimate, $286 T1, and 14%/24%/62% profit/stop/time-exit assumptions. T1 is not the full-position take-profit; the original calculated profit barrier is $295.239990234. Confirmation delays and gaps can produce substantially worse exits.
Publication checks: IQV remains on the independently fetched S&P 500 constituent list. The refreshed completed bars show no new breach of the retained structure; the earnings-call transcript ends with the call concluded. These scoped checks are not comprehensive company-event or legal clearance. en.wikipedia.finance.yahoobenzinga

Why Now

A fresh operating print, with a restrained forward interpretation

The relevant first disclosure was October 27 at 07:00 EDT, not the later earnings call. IQVIA reported quarterly revenue of $4.428 billion, adjusted EBITDA of $1.032 billion, adjusted EPS of $3.34, and R&D net new bookings of $3.2 billion, with 1.2 times book-to-bill. Reported growth was 8.0%, 8.7%, 11.3% and 15%, respectively. businesswire

The decider calculates increases of approximately 0.288% in the full-year revenue midpoint, 0.373% in adjusted EBITDA and 0.388% in adjusted EPS from the disclosed ranges. However, the revenue outlook also includes a larger acquisition contribution; the small headline raise does not establish an organic guidance acceleration. Contemporaneous expert coverage characterized full-year guidance as approximately inline. businesswireseekingalpha

Decider's causal thesis: stronger bookings, current execution and cash generation may support additional recognition over seven days, even without a large earnings-estimate upgrade. This is a repricing hypothesis—not an assumption that multiyear bookings turn into this week's revenue. The December 1 Investor Day is outside the forecast window and contributes no assumed payoff. The previously discussed $2.1 billion inactive-trial backlog adjustment is not treated as a fresh catalyst. businesswire

The market response is the strongest contradiction

The retained morning high was $284.50. In the completed 09:55–10:00 EDT bar, price opened at $280.88 and closed at $274.60; the subsequent recovery remained below the reported regular-phase VWAP. The publication bars through 10:55 EDT again reached $275.43, without establishing a sustained clearance of that nearby obstacle. finance.yahoo

Interpretation: the initial earnings enthusiasm did not hold. The decider therefore cut continuation assumptions before selecting IQV, rather than treating a cheaper quote as evidence of stronger business prospects. At the original research entry, price was only a calculated 0.311% above the $273.600006 pre-disclosure close. Exact disclosure-to-entry market and sector alpha was unavailable; it is not inferred from unmatched observations. finance.yahoo

Business And Market Context

IQVIA supplies clinical research services, commercial insights and healthcare intelligence. Its current issuer reporting uses two segments—Commercial Solutions and Research & Development Solutions—rather than the older three-segment description still carried by the market-data profile. Third-quarter segment revenues were $1.789 billion and $2.639 billion, respectively. businesswire

For this trade, the important business distinction is between demand indicators and cash realization. Bookings support the demand argument, while $825 million of operating cash flow and $667 million of free cash flow support current execution. Against that, September 30 cash was $2.249 billion, debt $16.067 billion, and net leverage 3.45 times. Positive cash generation does not remove financing or valuation sensitivity. businesswire

The retained market packet shows uneven rotation: RSP strength and eight of eleven positive sector windows coexist with SPY and QQQ below their completed 20- and 50-day averages and subaverage rebound volume. The official October 26 ten-year Treasury par yield was 5.00%. These observations support caution rather than a confirmed broad-market-crash conclusion. finance.yahoofinance.yahoohome.treasury

October 27's 10:00 EDT consumer-confidence release showed the index rising 7.5 points to 91.7, while expectations were 72.6 and spending intentions weakened. The decider retained a modest stabilization forecast rather than upgrading the market mean on the headline alone. prnewswire

The supplied portfolio already contains a healthcare position in LLY; IQV adds healthcare exposure rather than a wholly independent risk source. This is a portfolio-fit consideration, not an invented sector cap. The supplied active-public-position list does not contain IQV; imminent expiry of another position is not assumed to mean it has closed. These are task-supplied portfolio inputs, not independently verified broker records.

Factor Stack

Factor	Source-reported observation or calculation	Decider assessment
Catalyst/news	October 27 results: bookings +15%, adjusted EPS +11.3%; small, acquisition-qualified forward raise. businesswire	Fresh released information supports a possible recovery, but the guidance headline overstates the verified organic increment.
Growth/profitability	Revenue +8%; adjusted EBITDA +8.7%; free cash flow $667 million. businesswire	Execution supports the thesis; bookings are not guaranteed near-term revenue.
Financial resilience	Cash $2.249 billion, debt $16.067 billion, net leverage 3.45 times at September 30. businesswire	Cash generation supports debt service; leverage remains a material counterweight.
Valuation	Original entry divided by the disclosed full-year adjusted-EPS midpoint gives approximately 21.19 times, a decider calculation. businesswire	Not evidence that IQV is cheap; multiple expansion is an assumption, not a valuation entitlement.
Momentum/structure	Completed October 26 SMA20 266.2095, SMA50 263.9630, pre-event simple ATR14 7.858574; original entry approximately 1.049 ATR above SMA20. finance.yahofinance.yahoo	Trend is supportive, but the earnings reversal weakens immediate continuation.
Relative strength	September 29–October 26 endpoint excess: +1.56 points versus SPY, −3.30 points versus XLV. These are trailing observations, not forecasts. finance.yahoo	Market-relative resilience is qualified by healthcare-sector underperformance.
Volume	Latest completed-session RVOL calculation 1.283750 versus the preceding twenty full sessions; intraday share totals conflict with cumulative displayed volume. finance.yahofinance.yahoo	No certified heavy-volume acceptance, pace-adjusted intraday RVOL or precise event-VWAP confirmation is claimed.
Estimates/expert review	Current expert coverage described guidance as inline. No numerical analyst-revision series was established. seekingalpha	No invented positive revision trend.
Social confirmation	Retained targeted community evidence was an older, low-engagement aggregation rather than representative fresh bullish discussion. reddit	Sentiment confirmation is weak; this is a limitation, not a separate exclusion.

Technical calculations use completed, consistently adjusted daily observations through October 26. SMA is the mean of completed closes; true range is the maximum of high-minus-low and the absolute high/low gaps from the prior close; ATR14 is the simple mean of fourteen true ranges. The partial October 27 daily session is not included. finance.yaho

Investment Thesis

1. Retain residual operating upside without overstating the catalyst

Decider analysis: the fresh bookings and cash-generation evidence can support a modest recovery, but the small forward raise and failed opening surge justify low continuation odds. The thesis does not depend on a pending earnings release, a December presentation, or an unsupported numerical estimate-revision trend.

2. Keep the seven-day target separate from the path obstacles

The $286 T1 is the decider's seven-day estimate, anchored to the completed October 22 high of $282.98 and the observed $284.50 earnings-session high. Neither source reports a $286 forecast. The nearer $275.43 rebound high is first resistance, followed by retained supply around $280.235 and $284.50. Clearing the first obstacle is not equivalent to achieving T1 or the actual profit exit. finance.yahofinance.yahoo

Geometry	Original research freeze	Publication-price calculation, unchanged assumptions
Entry indication	$274.45001220703125, October 27 10:43 EDT	$274.2099914550781, October 27 10:56 EDT
Authored stop threshold	$266.00	$266.00
Conditional actual stop-exit estimate, before friction	$263.50	$263.50
First resistance diagnostic	$275.43	$275.43
Seven-day T1 estimate	$286.00	$286.00
T1 upside, calculated	4.2084%	4.2996%
Full-position profit barrier, calculated	$295.239990234	$295.432006836
Authored threshold distance, calculated	3.0789%	2.9941%
Conditional stop return, calculated	−3.9898%	−3.9058%

The quote and completed-bar observations are from October 27; the stop, stop-exit estimate and T1 are decider assumptions. Publication calculations change only the observed entry, not the authored target, probabilities, exit estimates or ranking. finance.yahoo

The actual profit barrier is E + 1.8 × (T1 − E): 1.8 times T1's percentage return, not 1.8 times its price. At the original entry, that is a 7.5751% full-position return before friction. The original raw T1 reward/risk is 1.3669, versus 2.4603 to the actual profit barrier; these are calculations, not independent evidence of favorable odds.

3. The positive mean is small and explicitly assumption-dependent

All figures in the following scenario table are uncalibrated decider estimates, not probabilities reported by IQVIA, the quote provider or a fitted historical model.

Mutually exclusive policy exit	Probability	Conditional payoff at original entry, before the common friction charge
Full-position profit barrier before stop/maturity	14%	+7.57514196%
Confirmed stop exit before profit/maturity	24%	−3.98980205%, using $263.50
Time exit when neither prior exit occurs	62%	+0.30%
Total	100%	Subtract 0.10 percentage point friction once

The 14% profit-exit assumption was decomposed by the decider into 70% first-resistance clearance × 20% subsequent barrier exit. This is a judgmental explanation, not empirical calibration or the probability of merely touching $286. No policy-matched historical reference class with dated observations and sample size was supplied.

Original arithmetic: 0.14 × 7.57514196 + 0.24 × (−3.98980205) + 0.62 × 0.30 − 0.10 = +0.18896738% expected net return. The expected-return/authored-risk diagnostic is 0.061375. These are derived values under the decider's assumptions.

Publication validation: substituting only the latest $274.2099914550781, October 27 10:56 EDT quote gives +0.23212312% net under unchanged scenarios. The earlier supplied pre-publication observation of $275.3999938964844 at 10:54 EDT yielded only +0.0189% under the same assumptions; it is not the latest quote. The refreshed completed bars and latest indication do not identify a new break of the retained support or clearance of the higher supply structure. finance.yahoo

The fixed-assumption zero-return sensitivity is approximately $275.505966. This is an arithmetic breakpoint, not a new limit order, mandatory trigger, or permission to raise the forecast if price rises. A subsequent nonpositive base forecast or material structural/news change requires upstream decision repair.

Matched-horizon benchmark and uncertainty

Decider's SPY assumptions: original entry $767.27001953125 at October 27 10:43 EDT, expected terminal $768.92478, adverse terminal $761.25088, zero eligible distribution, and 0.10 percentage point friction. The entry is a sourced observation; terminal values are judgmental forecasts supported directionally by the mixed market evidence, not source-reported price targets. finance.yaho

The resulting original benchmark estimate is +0.11566859% net, with an adverse estimate of −0.88448778%. SPY's October 30 payment belongs to the September 18 ex-date; a new October 27 holder has no in-window entitlement, and the next listed ex-date is December 18. No distribution is added to an unchanged price path and no expense is subtracted twice. ssga

Thus the original modeled stock excess is +0.07329879 percentage point. Deducting 1.46 points of decider-estimated model uncertainty gives −1.38670121 points. These comparisons retain the original synchronized SPY mark; no newly synchronized publication-time SPY comparison is claimed.

The coherent adverse IQV forecast keeps entry, authored stop, T1, horizon and execution policy fixed, but changes profit/stop/time probabilities to 10%/30%/60%, conditional stop exit to $260.50, conditional time return to −0.50%, and the SPY forecast to −0.88448778%. It produces approximately −1.1674% absolute and −0.2829% excess. The calculated minimum uncertainty needed to cover the stressed absolute-mean deterioration is 1.3564 points; the declared 1.46 points covers it. This stress is grounded in the observed reversal, acquisition-qualified guidance and leverage, while its numerical overrides remain decider estimates. finance.yahoobusinesswire

Profit-to-stop and profit-to-time shift headroom is only 1.634249 and 2.597887 probability points, respectively, at the original entry. Headroom is an arithmetic sensitivity—not an observed frequency. Uncertainty is applied once for ranking, not added again to stress losses or equated with ATR/VIX dispersion. Under the governing selection policy, negative stress or adjusted excess does not independently reject a supported positive base absolute-return forecast; confidence remains descriptive.

Opportunity cost and rejected finalists

The decider compared IQV, LMT and SPY on identical October 27 10:43 EDT to November 3 10:43 EST clocks. LMT's original entry was $623.6699829101562; it had the higher base absolute forecast, but a wider structural stop and larger uncertainty deduction. Those differences—not a confidence threshold—put it behind IQV. finance.yahoofinance.yahofinance.yaho

The following returns and uncertainties are decider estimates/calculations at their disclosed research freezes, not current quotes or source forecasts. Ranks are retained from the complete final gate.

Final-gate rank	Candidate / research quote time, October 27 ET	Base net	SPY excess	Uncertainty	Adjusted excess	Why not selected
1	IQV / 10:43	+0.1890%	+0.0733%	1.46 pp	−1.3867%	Selected; fragile positive base.
2	LMT / 10:43	+0.4920%	+0.3763%	2.30 pp	−1.9237%	Older, already-capitalized catalyst and wider structural risk.
3	CCL / 10:35	+0.3271%	+0.2154%	2.50 pp	−2.2846%	Remote stop, high beta and fuel/forecast uncertainty.
4	CNC / 10:35	+0.0784%	−0.0333%	2.30 pp	−2.3333%	Strong fresh guidance improvement, qualified by medical-cost and cash quality.
5	CDNS / 10:35	+0.3336%	+0.2219%	4.20 pp	−3.9781%	Margin/collection concerns and a demanding profit path.

LMT's October 22 guidance/backlog catalyst was older than IQV's; its initial F-35 arrangement was not a funded order or guaranteed seven-day revenue. investors.loreuters CCL's company catalyst dates to September 29; October 27 peer/oil read-through is not a new Carnival guidance raise. carnivalcorpinvestopedia CNC's October 27 EPS-floor increase and medical-cost improvement are substantial, but adjustments, member mix and payment timing qualify the recurring economics. investors.ceprnewswire CDNS's October 26 after-close raise competes with margin compression, longer collections and unchanged cash-flow guidance. finance.yahos206.q4cdn

LMT's coherent stress produces −1.6051% absolute / −0.7207% excess, with 2.0971 points minimum uncertainty, covered by its 2.30-point deduction. Its profit/stop/time probabilities become 10%/20%/70%, conditional stop $566, and time return −0.8%, alongside the same weaker SPY forecast. The decider applied the challenge symmetrically; IQV's ranking advantage remains an uncalibrated point estimate, not statistical superiority.

The other three alternatives use an eight-minute-earlier 10:35 freeze, matched to November 3 10:35, and a +0.1117544941% SPY estimate. They are not simultaneous final-pair legs. All four supplied viable rejected-finalist scenarios are preserved above in the structured fields. CDNS has a handoff diagnostic inconsistency: numeric first resistance is $332.14, whereas its entry-quality text names $334.96; neither is silently substituted, and CDNS is not an execution recommendation.

The remaining completed gate included DUK and VZ with negative base forecasts, and EXE, ZTS and CASY with documented hard exclusions. EXE had earnings scheduled after the October 27 close, before the next regular-session stop window; ZTS and CASY had failed mandatory catalyst-support confirmation. No hypothetical scenarios are invented for those hard exclusions. investors.exfinance.yahoinvestor.zoefinance.yahoinvestor.casfinance.yaho

Risks And Thesis Breakers

A better print can still be fully priced. The guidance increase is small and acquisition-qualified; the failed $284.50 extension is direct counterevidence to effortless continuation. A durable failure of the event structure or new information undermining bookings/cash conversion would require reassessment, not a higher target or improvised probabilities. businesswirefinance.yahoo
The stop is deliberately delayed. A quote touching $266 does not create an immediate threshold fill under this policy. Average-price confirmation, overnight gaps and the hard-loss confirmation can all permit greater loss. The $263.50 conditional stop estimate is not a worst-case floor.
Leverage and rates matter. Net leverage of 3.45 times and approximately 5% long Treasury yields leave financing and valuation sensitivity even with positive free cash flow. businesswirehome.treasury
Macro releases can overwhelm company-specific recognition. The retained publisher schedules place the October 28 FOMC decision at 14:00 EDT, October 29 GDP/PCE at 08:30 EDT, October 30 ECI at 08:30 EDT, November 2 ISM manufacturing at 10:00 EST, and November 3 JOLTS at 10:00 EST inside the selected interval. These are common-market risks, not company-specific binary-event exclusions. federalreserbea.govbls.govismworld.orgbls.govdol.gov
Event checks have limits. Publication reread the October 27 primary release and the transcript's conclusion; the latter explicitly warns of automated transcription errors. No specific unreleased immediate-window IQV binary was identified in the retained checks, but no exhaustive legal/regulatory docket or complete seven-day issuer calendar is certified. Primary release figures govern over transcript discrepancies. businesswirebenzinga
Data quality constrains technical conviction. The decider's intraday bars summed to 692,945 shares, exceeding the then-displayed 599.3K cumulative volume even before omitted opening bars. The refreshed twelve-bar window is not the full session and does not resolve that earlier discrepancy. Reported phase VWAP is a limited diagnostic, not event-anchored proof; exact volume-based acceptance and pace-adjusted RVOL remain unverified. finance.yahoo
The mean can disappear on modest price drift. At unchanged assumptions, the approximately $275.505966 zero-return point is close. A later quote at which the base becomes nonpositive, a broken authored structure, or material news/barrier change requires an upstream synchronized repair. This report does not authorize silently moving the stop, raising the odds, extending the horizon or selecting a replacement.

The decider did not activate the mandatory over-extension route for IQV: the retained $284.50–$266.609985 session range was a calculated 2.2765 pre-event ATR, below 2.5, and the observed repricing was below roughly 10%; no separate high-beta/failed-breakout activation was established. This is not certification of an event-VWAP base. The $266 stop is tied below the event low rather than justified solely by pre-event moving averages. finance.yahoofinance.yaho

Investment Recommendation

BUY IQV now at the supported publication indication, retaining the decider's Momentum classification and Low confidence. The latest available observation is $274.2099914550781 at October 27, 2026, 10:56 EDT; the publication check retrieved it at 10:57:33 EDT. Its unchanged-scenario positive net forecast preserves the upstream selection. A research recommendation is not execution clearance at every later price, and no exact fill is promised. finance.yahoo

Exact stop and exit plan

Authored stop: $266. The trailing 60-minute average must remain below that level for 120 minutes to confirm the ordinary stop. Do not describe this as an immediate stop-market order at $266.
Hard loss: 15%, confirmed for 10 minutes. At the original research entry this threshold is a calculated $233.282510; it is not a guaranteed floor. Overnight gaps, averaging and confirmation delays can cause worse realized losses.
Conditional actual stop estimate: $263.50 before friction. The decider allowed $2.50 below the authored threshold—approximately 0.32 pre-event ATR—for delay/gap effects. This is a conditional mean estimate, not a maximum loss or promised execution price.
T1: $286; full-position profit barrier: 1.8 times its percentage return. The original barrier is approximately $295.239990234; at the publication indication the formula produces $295.432006836. There is no invented partial sale at T1, discretionary trailing stop or extension of the forecast.
Friction: 0.10 percentage point, charged once, representing the required 0.1% adverse exit slippage. Stop deterioration is already in the conditional stop estimate and is not charged a second time.
Early exits leave cash through scheduled maturity, without assumed reinvestment or additional interest credit. SPY is compared as buy-and-hold through the same horizon.

Seven-day clocks, including daylight saving

Clock	Authored decision freeze
Research entry	Tuesday, October 27, 2026, 10:43 EDT (UTC−04:00)
Nominal seven-local-calendar-day maturity	Tuesday, November 3, 2026, 10:43 EST (UTC−05:00)
First scheduled liquid time exit	November 3, 10:43 EST, within the scheduled regular session
Elapsed duration	169 hours, because the interval crosses November 1 daylight-saving reversal

These are seven local calendar days, not seven trading sessions. The retained exchange calendar supports the November 3 regular-session exit. The publication quote is a freshness observation, not a newly executed entry; it does not silently overwrite the original research clocks or matched SPY comparison. Actual entry must be paired with the corresponding seven-local-day maturity under the same policy; if maturity is outside a liquid session, the first liquid exit can be later. nist.govnyse

Bottom line—decider judgment: IQV is the highest-ranked eligible stock under the prescribed positive-absolute-return gate, but its expected benefit is small and much less robust than its headline earnings growth might suggest. The strongest reason to hesitate is the failed opening surge alongside acquisition-qualified guidance, not an invented bearish-market label. No separate VOO-versus-Gold-cash allocation recommendation is made: that review is conditional on audited stock N/A, and this decision remains a selected stock.